Press Releases on November 6, 2024 - EIN Presswire - Press Release Distribution Service

Published on November 6, 2024 - 13:00 GMT

Fulcrum Therapeutics to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, November 13, 2024 at 8:...

CAMBRIDGE, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 6, 2024 - 13:00 GMT

Twin Disc Approves a Quarterly Cash Dividend

MILWAUKEE, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Twin Disc, Inc. (NASDAQ: TWIN), today announced that the Board of Directors (the "Board") approved a regular quarterly cash dividend of $0.04 per share payable on December 2, 2024, to shareholders of …

Distribution channels: Banking, Finance & Investment Industry, Electronics Industry ...

Published on November 6, 2024 - 13:00 GMT

iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference

NASHUA, N.H., Nov. 06, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today announced …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 6, 2024 - 13:00 GMT

Protara Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference

NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in a …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on November 6, 2024 - 13:00 GMT

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that David …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 6, 2024 - 13:00 GMT

NV5 Awarded $7 Million Lake Havasu Bridge and Roadway Infrastructure Improvement Contract

HOLLYWOOD, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) -- NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of technology, certification, and consulting solutions, announced today that it has been awarded a $7 million contract to lead the …

Distribution channels: Business & Economy, Technology ...

Published on November 6, 2024 - 13:00 GMT

Humacyte to Present Third Quarter Financial Results and Provide Corporate Update on November 8, 2024

DURHAM, N.C., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will release its financial results for the …

Distribution channels: Technology ...

Published on November 6, 2024 - 13:00 GMT

red violet to Participate in the Southwest IDEAS Investor Conference

BOCA RATON, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced that it will participate in the Southwest IDEAS Investor Conference being held in Dallas on …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on November 6, 2024 - 13:00 GMT

Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit ...

CUPERTINO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on November 6, 2024 - 13:00 GMT

Keros Therapeutics to Present at the Guggenheim Healthcare Innovation Conference

LEXINGTON, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments to treat a wide range of …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 6, 2024 - 13:00 GMT

Lexicon Pharmaceuticals to Participate in the Jefferies London Global Healthcare Conference

THE WOODLANDS, Texas, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the Jefferies London Global Healthcare Conference. Lexicon management including Mike Exton, Lexicon’s chief executive …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 6, 2024 - 13:00 GMT

PDS Biotech to Announce Third Quarter Financial Results on November 14, 2024 at 8:30 a.m. Eastern Time

PRINCETON, N.J., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 6, 2024 - 13:00 GMT

Edible Garden Schedules Third Quarter 2024 Financial Results and Business Update Conference Call

BELVIDERE, NJ, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic and sustainable produce and products, …

Distribution channels: Agriculture, Farming & Forestry Industry, Environment ...

Published on November 6, 2024 - 13:00 GMT

Mobivity Schedules Third Quarter 2024 Conference Call for Thursday, November 14, 2024

PHOENIX, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Mobivity Holdings Corp. (OTCQB: MFON), a global provider of personalized reward performance solutions for brands, today announced that it has scheduled its conference call to announce results for the third quarter …

Distribution channels: Technology ...

Published on November 6, 2024 - 13:00 GMT

Recce Pharmaceuticals Advances Patient Dosing to Final Stages in Phase II Trial for Acute Bacterial Skin and Skin Structure ...

Trial reaches dosing milestone, with 20 of the 30 total patients dosed All patients dosed met the primary endpoints of the study, either a cure or notable improvement following treatment with RECCE® 327 topical gel (R327G) Patient dosing on track to be …

Distribution channels: Technology ...

Published on November 6, 2024 - 13:00 GMT

Janover Reports Third Quarter 2024 Financial Results and Provides Business Update

BOCA RATON, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Janover Inc. (Nasdaq: JNVR) (“Janover” or the “Company”), an AI-enabled platform connecting the commercial real estate industry, provided a business update and announced its financial results for the …

Distribution channels: Business & Economy, Real Estate & Property Management ...

Published on November 6, 2024 - 13:00 GMT

Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024

MORRISVILLE, N.C., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today it will now report its third quarter 2024 …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on November 6, 2024 - 13:00 GMT

Twin Disc Announces First Quarter Results

MILWAUKEE, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Twin Disc, Inc. (NASDAQ: TWIN) today reported results for the first quarter ended September 27, 2024. Fiscal First Quarter 2025 Highlights Sales increased 14.7% year-over-year to $72.9 million Gross margin of 26 …

Distribution channels: Business & Economy, Electronics Industry ...

Published on November 6, 2024 - 13:00 GMT

Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13

DALLAS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system …

Distribution channels: Technology ...

Published on November 6, 2024 - 13:00 GMT

LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency

NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the official opening of its state-of-the-art affiliated pharmacy, marking an important milestone in creating a …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...